All sites C00-96,D32-33,D42-43,D45-47,D76 180 88.6 4.6 2.6 1.9 2.3
Mouth, pharynx C00-14 3 100.0 - - - -
  Lip C00 - - - - - -
  Tongue C02 1 100.0 - - - -
  Mouth, other C03-06 1 100.0 - - - -
  Salivary glands C07-08 0 100.0 - - - -
  Pharynx C01,C09-14 1 100.0 - - - -
Digestive organs C15-26 36 79.1 8.2 4.4 4.4 3.8
  Oesophagus C15 2 100.0 - - - -
  Stomach C16 2 91.7 8.3 - - -
  Small intestine C17 1 100.0 - - - -
  Colon C18 15 100.0 - - - -
  Rectum, rectosigmoid C19-20 3 100.0 - - - -
  Anus C21 1 66.7 33.3 - - -
  Liver C22 2 45.5 36.4 9.1 9.1 -
  Gallbladder, bile ducts C23-24 2 60.0 - 10.0 20.0 10.0
  Pancreas C25 9 43.2 20.5 13.6 9.1 13.6
  Other digestive organs C26 0 - - - 100.0 -
Respiratory organs C30-39 13 69.7 19.7 4.5 3.0 3.0
  Nose, sinuses C30-31 1 100.0 - - - -
  Larynx, epiglottis C32 - - - - - -
  Lung, trachea C33-34 12 67.2 21.3 4.9 3.3 3.3
  Mediastinum, pleura C38 0 100.0 - - - -
Bone C40-41 1 75.0 - 25.0 - -
Melanoma of the skin C43 4 100.0 - - - -
Skin, non-melanoma C44 9 100.0 - - - -
Mesothelioma C45 0 100.0 - - - -
Autonomic nervous system C47 - - - - - -
Soft tissues C48-49 2 100.0 - - - -
Breast C50 55 98.6 0.4 0.4 0.4 0.4
Female genital organs C51-58 21 98.1 - - 1.9 -
  Cervix uteri C53 2 100.0 - - - -
  Corpus uteri C54 10 100.0 - - - -
  Uterus, other C55,C58 0 - - - 100.0 -
  Ovary C56 5 100.0 - - - -
  Other female genital C51-52,C57 3 100.0 - - - -
Urinary organs C64-68 11 96.2 1.9 1.9 - -
  Kidney C64 5 96.0 4.0 - - -
  Bladder and urinary tract2 C65-68 6 96.4 - 3.6 - -
Eye C69 0 100.0 - - - -
Brain, central nervous system C70-72,D32-33,D42-43 5 83.3 - 4.2 4.2 8.3
Thyroid gland C73 2 100.0 - - - -
Other endocrine glands C74-75 - - - - - -
Illdefined or unknown C76,C80 4 22.2 33.3 22.2 11.1 11.1
Lymphoid and haematopoietic tissue C81-96,D45-47,D76 13 74.2 7.6 6.1 1.5 10.6
  Hodgkin lymphoma C81 1 100.0 - - - -
  Non-Hodgkin lymphoma C82-86,C96,D76 6 100.0 - - - -
  Malignant immunoproliferative diseases C88 - - - - - -
  Myeloma and other plasma cell tumors C90 2 37.5 12.5 37.5 - 12.5
  Leukaemia C91-95 3 68.8 12.5 6.3 - 12.5
  Myelodysplastic syndromes D46 1 28.6 28.6 - 14.3 28.6
  Myeloproliferaitive neoplasms D45,D47 1 33.3 - - - 66.7
Not included above
  Carcinoma in situ of the breast D05 4 100.0 - - - -
  Cervix uteri, non-invasive neoplasms 16 100.0 - - - -
  Borderline tumour of the ovary D39 3 86.7 - - - 13.3
  Basal cell carcinoma of the skin 46 100.0 - - - -
1 The following order of preference for confirmation of the diagnosis is used:
1. Histology (including autopsy, and bone marrow and blood smear examination in leukaemias)
2. Cytology
3. Surgery (including endoscopy), autopsy without histology, X-ray and some specified laboratory examinations
4. Clinical examination only
2 PUNLMP and ca in situ of the uroepithelium are included.